1. Home
  2. LXRX vs FBIZ Comparison

LXRX vs FBIZ Comparison

Compare LXRX & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FBIZ
  • Stock Information
  • Founded
  • LXRX 1995
  • FBIZ 1909
  • Country
  • LXRX United States
  • FBIZ United States
  • Employees
  • LXRX N/A
  • FBIZ N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FBIZ Major Banks
  • Sector
  • LXRX Health Care
  • FBIZ Finance
  • Exchange
  • LXRX Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • LXRX 428.8M
  • FBIZ 390.3M
  • IPO Year
  • LXRX 2000
  • FBIZ N/A
  • Fundamental
  • Price
  • LXRX $1.52
  • FBIZ $50.26
  • Analyst Decision
  • LXRX Buy
  • FBIZ Buy
  • Analyst Count
  • LXRX 5
  • FBIZ 3
  • Target Price
  • LXRX $3.23
  • FBIZ $58.67
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • FBIZ 39.5K
  • Earning Date
  • LXRX 11-11-2025
  • FBIZ 10-30-2025
  • Dividend Yield
  • LXRX N/A
  • FBIZ 2.27%
  • EPS Growth
  • LXRX N/A
  • FBIZ 22.50
  • EPS
  • LXRX N/A
  • FBIZ 5.60
  • Revenue
  • LXRX $58,432,000.00
  • FBIZ $150,952,000.00
  • Revenue This Year
  • LXRX $67.21
  • FBIZ $17.98
  • Revenue Next Year
  • LXRX N/A
  • FBIZ $8.16
  • P/E Ratio
  • LXRX N/A
  • FBIZ $9.11
  • Revenue Growth
  • LXRX 1504.83
  • FBIZ 8.24
  • 52 Week Low
  • LXRX $0.28
  • FBIZ $41.50
  • 52 Week High
  • LXRX $2.18
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 70.28
  • FBIZ 46.54
  • Support Level
  • LXRX $1.28
  • FBIZ $49.23
  • Resistance Level
  • LXRX $1.42
  • FBIZ $51.92
  • Average True Range (ATR)
  • LXRX 0.10
  • FBIZ 0.98
  • MACD
  • LXRX 0.02
  • FBIZ -0.21
  • Stochastic Oscillator
  • LXRX 81.00
  • FBIZ 33.05

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: